Prescription pattern of human recombinant 1-34 parathyroid hormone (teriparatide, forsteo®) in Sweden

被引：0
|
作者：
Ljunggren, O. [1 ]
Toll, A. [2 ]
Myren, K.-J. [2 ]
Mullarney, T. [3 ]
机构：
[1] Uppsala Univ, Dept Med Sci, S-75105 Uppsala, Sweden
[2] Eli Lilly Sweden AB, Stockholm, Sweden
[3] Eli Lillly UK Ltd, Erl Wood, England
来源：
OSTEOPOROSIS INTERNATIONAL | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S71 / S72
页数：2
相关论文
共 50 条
  • [41] TEH OCCURRENCE OF HYPERCALCAEMIA IN PATIENTS COMMENCING RECOMBINANT PARATHYROID HORMONE (1-34) THERAPY
    Mahon, J. H.
    McCarron, E. H.
    Robinson, V.
    Drumm, B.
    Fitzgerald, K.
    Walsh, J. B.
    Casey, M. C.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S344 - S344
  • [42] Effects of recombinant human parathyroid hormone (1-34) on cell proliferation, chemokine expression and the Hedgehog pathway in keratinocytes
    Bu, Xiaolin
    Bi, Xinling
    Wang, Wuqing
    Shi, Yuling
    Hou, Qiang
    Gu, Jun
    MOLECULAR MEDICINE REPORTS, 2018, 17 (04) : 5589 - 5594
  • [43] Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34)
    Alkhiary, YM
    Gerstenfeld, LC
    Krall, E
    Westmore, M
    Sato, M
    Mitlak, BH
    Einhorn, TA
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2005, 87A (04): : 731 - 741
  • [44] Efficacy and safety of recombinant human parathyroid hormone (1-34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis
    Deng, Jing
    Feng, Zhengping
    Li, Yue
    Pan, Tingting
    Li, Qifu
    Zhao, Changhong
    MEDICINE, 2018, 97 (47)
  • [45] Preparation and characterization of a novel recombinant human parathyroid hormone (1-34) analog (Gly1-Gln26-rhPTH(1-34)) with enhanced biological activity
    Xu, Xiao-Chao
    Zhong, Shao-Dong
    Kai, Fan
    Li, Ling-Rui
    Liu, Chao
    Liu, Bo
    Bao, Jin-Ku
    PROTEIN AND PEPTIDE LETTERS, 2008, 15 (08): : 854 - 860
  • [46] Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women
    Tashjian, AH
    Chabner, BA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (07) : 1151 - 1161
  • [47] In vivo studies of the inhibitory effects of parathyroid hormone(1-34) and parathyroid hormone-related protein(1-34) on ruminal motility
    Harmeyer, J
    Care, AD
    COMPARATIVE ENDOCRINOLOGY OF CALCIUM REGULATION, 1996, : 171 - 175
  • [48] Nasal administration of a novel recombinant human parathyroid hormone (1-34) analog for the treatment of osteoporosis of ovariectomized rats
    Shi Xiaoming
    Wang Chunxiao
    Zhuang Zhihua
    Lu Jingning
    Liu Jingjing
    Wu Jie
    Cao Rongyue
    Li Taiming
    REGULATORY PEPTIDES, 2011, 170 (1-3) : 52 - 56
  • [49] Anabolic effects of recombinant human parathyroid hormone (1-84) and synthetic human parathyroid hormone (1-34) on the mandibles of osteopenic ovariectomized rats with maxillary molar extraction
    Kawane, T
    Takahashi, S
    Saitoh, H
    Okamoto, H
    Kubodera, N
    Horiuchi, N
    HORMONE AND METABOLIC RESEARCH, 2002, 34 (06) : 293 - 302
  • [50] BIOLOGIC ACTIVITIES OF PARATHYROID-HORMONE (1-34) AND PARATHYROID-HORMONE - RELATED PEPTIDE (1-34) IN ISOLATED PERFUSED RAT FEMUR
    LOPEZHILKER, S
    MARTIN, KJ
    SUGIMOTO, T
    SLATOPOLSKY, E
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1992, 119 (06): : 738 - 743
12345